SCHEMBL15079872

SCHEMBL15079872

Fc1ccc(OCCc2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.69
RAB9A P51151 1/20 0.69
FFAR1 O14842 2/20 0.61
LTA4H P09960 1/20 0.59
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA7 P43166 1/20 0.59
CA9 Q16790 1/20 0.59
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C19 P33261 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
GAA P10253 1/20 0.52
MAOA P21397 3/20 0.51
MAOB P27338 3/20 0.51
DRD2 P14416 1/20 0.50
DRD4 P21917 1/20 0.50
DRD3 P35462 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28156792 0.92 FFAR1 (0.60) NPC1RAB9AFFAR1LTA4HCA12
SCHEMBL6282133 0.92 NPC1 (0.58) NPC1RAB9AFFAR1LTA4HCA12
SCHEMBL9456979 0.91 NPC1 (0.80) NPC1RAB9AFFAR1LTA4HCA12
SCHEMBL15079869 0.89 MAOB (0.58) NPC1RAB9AFFAR1LTA4HCYP1A2
SCHEMBL1070131 0.87 NPC1 (0.73) NPC1RAB9AFFAR1LTA4HCA12
SCHEMBL8671057 0.85 CYP1A2 (0.66) NPC1RAB9ALTA4HCYP1A2CYP2D6
SCHEMBL320783 0.84 MAOB (0.55) NPC1RAB9AFFAR1LTA4HMAOB
SCHEMBL11857770 0.83 NPC1 (0.69) NPC1RAB9AFFAR1LTA4HCA12
SCHEMBL5696724 0.83 NPC1 (0.69) NPC1RAB9AFFAR1LTA4HCA12
Methane SCHEMBL28866356 0.83 NPC1 (0.68) NPC1RAB9AFFAR1LTA4HCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102791690-B As the disubstituted pyridines derivative of anticarcinogen OTSUKA PHARMACEUTICAL CO.,LTD. (JP) 2015-12-02 CN disclosed
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
WO-2013093320-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS ARG1, TYR, NOS1 NPC1 2259/4885RAB9A 1963/4885FFAR1 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.